Georgia

Georgia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.09 (1.48 - 2.83) 2015 Modelled WHO
2.5 (1.90 - 3) 2016 Modelled Razavi-Shearer et al, 2018
2.64 (2.22 - 3.14) 2013 Modelled Schweitzer et al, 2015
2.9 (2.38 - 3.51) 2017 Survey/reported Kasradze et al, 2017
1.48 (1.46 - 1.50) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.61 (1.59 - 1.64) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.61 - 1.66) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.66 (1.64 - 1.68) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.67 - 1.72) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.73 (1.71 - 1.76) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.75 - 1.80) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.82 (1.80 - 1.85) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.86 (1.84 - 1.89) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.9 (1.87 - 1.92) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.90 - 1.95) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.92 - 1.98) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.98 (1.95 - 2.01) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.97 - 2.03) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.02 (1.99 - 2.05) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (2.01 - 2.08) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (2.05 - 2.12) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (2.08 - 2.15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (2.11 - 2.19) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (2.12 - 2.20) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (2.12 - 2.20) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (2.11 - 2.19) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.14 (2.10 - 2.17) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (2.09 - 2.16) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (2.08 - 2.15) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (2.07 - 2.15) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (2.07 - 2.15) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (2.06 - 2.14) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (2.05 - 2.14) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (2.05 - 2.14) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.58 - 1.63) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.7 2021 Survey/reported Georgia National Center for Disease Control and Public Health, 2022
2.9 2015 Survey/reported Kasradze A et al, 2020
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.26 (0.16 - 0.42) 2015 Modelled WHO
0.24 (0.21 - 0.28) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.31 (0.27 - 0.36) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.28 - 0.37) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.34 (0.29 - 0.38) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.29 - 0.38) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.28 - 0.39) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.34 (0.29 - 0.39) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.34 (0.29 - 0.40) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.30 - 0.41) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.31 - 0.42) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.32 - 0.44) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.36 - 0.49) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.44 - 0.58) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.54 - 0.70) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.64 - 0.83) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.73 - 0.96) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.82 - 1.08) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.90 - 1.23) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.2 (0.97 - 1.39) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.03 - 1.54) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.42 (1.09 - 1.69) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.21 - 1.78) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.34 - 1.88) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.73 (1.46 - 1.96) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (1.55 - 2.03) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.83 (1.58 - 2.06) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.83 (1.58 - 2.06) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.83 (1.57 - 2.06) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.82 (1.54 - 2.06) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (1.49 - 2.05) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.42 - 2.04) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.03 2020 Survey/reported Georgia National Center for Disease Control and Public Health, 2022
0.06 (0.04 - 0.08) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
100,000 (76,000 - 117,000) 2016 Modelled Razavi-Shearer et al, 2018
54,203 (53,602 - 54,860) 2019 Modelled IHME, GBD 2019 (accessed 2020)
56,155 (55,501 - 56,921) 2019 Modelled IHME, GBD 2019 (accessed 2022)
57,186 (56,491 - 57,920) 2018 Modelled IHME, GBD 2019 (accessed 2022)
58,348 (57,500 - 59,244) 2017 Modelled IHME, GBD 2019 (accessed 2022)
59,901 (59,193 - 60,696) 2016 Modelled IHME, GBD 2019 (accessed 2022)
61,803 (61,016 - 62,715) 2015 Modelled IHME, GBD 2019 (accessed 2022)
63,688 (62,922 - 64,555) 2014 Modelled IHME, GBD 2019 (accessed 2022)
65,854 (65,058 - 66,692) 2013 Modelled IHME, GBD 2019 (accessed 2022)
68,168 (67,327 - 69,063) 2012 Modelled IHME, GBD 2019 (accessed 2022)
70,466 (69,548 - 71,455) 2011 Modelled IHME, GBD 2019 (accessed 2022)
72,563 (71,514 - 73,658) 2010 Modelled IHME, GBD 2019 (accessed 2022)
74,512 (73,519 - 75,566) 2009 Modelled IHME, GBD 2019 (accessed 2022)
76,528 (75,533 - 77,584) 2008 Modelled IHME, GBD 2019 (accessed 2022)
78,575 (77,565 - 79,661) 2007 Modelled IHME, GBD 2019 (accessed 2022)
80,651 (79,548 - 81,757) 2006 Modelled IHME, GBD 2019 (accessed 2022)
82,791 (81,564 - 84,011) 2005 Modelled IHME, GBD 2019 (accessed 2022)
85,373 (84,122 - 86,622) 2004 Modelled IHME, GBD 2019 (accessed 2022)
88,572 (87,166 - 89,897) 2003 Modelled IHME, GBD 2019 (accessed 2022)
91,995 (90,457 - 93,445) 2002 Modelled IHME, GBD 2019 (accessed 2022)
95,192 (93,461 - 96,770) 2001 Modelled IHME, GBD 2019 (accessed 2022)
97,741 (95,816 - 99,508) 2000 Modelled IHME, GBD 2019 (accessed 2022)
99,578 (97,741 - 101,332) 1999 Modelled IHME, GBD 2019 (accessed 2022)
101,024 (99,263 - 102,687) 1998 Modelled IHME, GBD 2019 (accessed 2022)
102,215 (100,543 - 103,877) 1997 Modelled IHME, GBD 2019 (accessed 2022)
103,320 (101,577 - 105,005) 1996 Modelled IHME, GBD 2019 (accessed 2022)
104,582 (102,830 - 106,397) 1995 Modelled IHME, GBD 2019 (accessed 2022)
106,008 (104,242 - 107,828) 1994 Modelled IHME, GBD 2019 (accessed 2022)
107,366 (105,562 - 109,263) 1993 Modelled IHME, GBD 2019 (accessed 2022)
108,545 (106,634 - 110,507) 1992 Modelled IHME, GBD 2019 (accessed 2022)
109,441 (107,222 - 111,519) 1991 Modelled IHME, GBD 2019 (accessed 2022)
109,998 (107,546 - 112,320) 1990 Modelled IHME, GBD 2019 (accessed 2022)
78,000 2021 Survey/reported Georgia National Center for Disease Control and Public Health, 2022
80,000 2015 Survey/reported Kasradze A et al, 2020
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
10 (7.31 - 13.50) 2019 Modelled IHME, GBD 2019 (accessed 2020)
8.97 (6.67 - 11.49) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9.18 (6.85 - 11.83) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9.3 (7.02 - 11.92) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9.09 (6.81 - 11.65) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9.25 (7.04 - 11.85) 1994 Modelled IHME, GBD 2019 (accessed 2022)
8.83 (6.72 - 11.24) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9.76 (7.45 - 12.37) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9.05 (6.82 - 11.46) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8.65 (6.55 - 10.93) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10.39 (7.99 - 13.23) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10.71 (8.22 - 13.52) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10.82 (8.40 - 13.69) 2001 Modelled IHME, GBD 2019 (accessed 2022)
11.18 (8.64 - 14.03) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11.28 (8.69 - 14.03) 2003 Modelled IHME, GBD 2019 (accessed 2022)
11.64 (9.04 - 14.67) 2004 Modelled IHME, GBD 2019 (accessed 2022)
11.2 (8.76 - 13.89) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11.36 (8.80 - 14.10) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10.98 (8.55 - 13.90) 2007 Modelled IHME, GBD 2019 (accessed 2022)
11.12 (8.63 - 14.04) 2008 Modelled IHME, GBD 2019 (accessed 2022)
11.12 (8.62 - 14.14) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11.1 (8.69 - 14.04) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11.06 (8.53 - 14.08) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10.89 (8.33 - 13.92) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10.63 (8.06 - 13.75) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9.94 (7.63 - 12.76) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10.14 (7.82 - 13.08) 2014 Modelled IHME, GBD 2019 (accessed 2022)
9.42 (7.11 - 12.32) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9.7 (7.40 - 12.61) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10.03 (7.31 - 13.46) 2019 Modelled IHME, GBD 2019 (accessed 2022)
9.57 (7.21 - 12.63) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
800 2016 Modelled WHO
494 (368 - 633) 1990 Modelled IHME, GBD 2019 (accessed 2022)
502 (375 - 647) 1991 Modelled IHME, GBD 2019 (accessed 2022)
504 (380 - 646) 1992 Modelled IHME, GBD 2019 (accessed 2022)
486 (364 - 623) 1993 Modelled IHME, GBD 2019 (accessed 2022)
487 (371 - 624) 1994 Modelled IHME, GBD 2019 (accessed 2022)
458 (349 - 583) 1995 Modelled IHME, GBD 2019 (accessed 2022)
441 (334 - 558) 1996 Modelled IHME, GBD 2019 (accessed 2022)
454 (342 - 575) 1997 Modelled IHME, GBD 2019 (accessed 2022)
480 (367 - 609) 1998 Modelled IHME, GBD 2019 (accessed 2022)
501 (385 - 638) 1999 Modelled IHME, GBD 2019 (accessed 2022)
507 (389 - 639) 2000 Modelled IHME, GBD 2019 (accessed 2022)
501 (389 - 634) 2001 Modelled IHME, GBD 2019 (accessed 2022)
508 (392 - 637) 2002 Modelled IHME, GBD 2019 (accessed 2022)
508 (394 - 640) 2004 Modelled IHME, GBD 2019 (accessed 2022)
502 (386 - 624) 2003 Modelled IHME, GBD 2019 (accessed 2022)
486 (377 - 604) 2005 Modelled IHME, GBD 2019 (accessed 2022)
472 (369 - 585) 2006 Modelled IHME, GBD 2019 (accessed 2022)
455 (354 - 576) 2007 Modelled IHME, GBD 2019 (accessed 2022)
455 (353 - 574) 2008 Modelled IHME, GBD 2019 (accessed 2022)
448 (351 - 566) 2009 Modelled IHME, GBD 2019 (accessed 2022)
435 (336 - 554) 2011 Modelled IHME, GBD 2019 (accessed 2022)
443 (343 - 563) 2010 Modelled IHME, GBD 2019 (accessed 2022)
424 (324 - 542) 2012 Modelled IHME, GBD 2019 (accessed 2022)
410 (311 - 531) 2013 Modelled IHME, GBD 2019 (accessed 2022)
388 (299 - 500) 2014 Modelled IHME, GBD 2019 (accessed 2022)
377 (290 - 484) 2015 Modelled IHME, GBD 2019 (accessed 2022)
351 (265 - 459) 2017 Modelled IHME, GBD 2019 (accessed 2022)
365 (279 - 475) 2016 Modelled IHME, GBD 2019 (accessed 2022)
354 (267 - 467) 2018 Modelled IHME, GBD 2019 (accessed 2022)
367 (268 - 493) 2019 Modelled IHME, GBD 2019 (accessed 2022)
367 (268 - 493) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1997 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 1999 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 18) 2000 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 11) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2014 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2016 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 30) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
94 2019 Survey/reported WHO/UNICEF
97 2018 Survey/reported WHO/UNICEF
94 2017 Survey/reported WHO/UNICEF
94 2016 Survey/reported WHO/UNICEF
93 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
80 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
93 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
73 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
97 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
92 2004 Survey/reported WHO/UNICEF
90 2003 Survey/reported WHO/UNICEF
80 2002 Survey/reported WHO/UNICEF
69 2001 Survey/reported WHO/UNICEF
97 2020 Survey/reported WHO/UNICEF
95 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
94 2019 Survey/reported WHO/UNICEF
88 2020 Survey/reported WHO/UNICEF
85 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
31 (16 - 271) 2015 Survey/reported Georgia National Centre for Disease Control and Public Health, 2015; Curatio International Foundation, 2015; Eurasia Harm Reduction Network, 2015
78 2021 Survey/reported Georgia Technical Adviosry Group
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.9 (3.10 - 4.80) 2015 Survey/reported Curatio International Foundation, 2015
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2003
Eligible for HBV generic medicines
HBV elimination goal
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based, Birth cohort
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
5.4 (4.60 - 6.40) 2015 Survey/reported Hagan et al, 2015
4.2 (3 - 4.20) 2015 Modelled Blach et al, 2017
3.65 (2.96 - 4.46) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3.67 (2.97 - 4.45) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.67 (2.96 - 4.46) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.65 (2.98 - 4.43) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.64 (2.99 - 4.44) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.7 (3.06 - 4.46) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.84 (3.21 - 4.59) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.02 (3.40 - 4.74) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.17 (3.52 - 4.87) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.24 (3.58 - 4.95) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.25 (3.60 - 4.95) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4.26 (3.61 - 4.96) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4.26 (3.60 - 4.95) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4.26 (3.59 - 4.97) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4.26 (3.57 - 4.98) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.28 (3.60 - 5) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.32 (3.63 - 5.06) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.36 (3.67 - 5.11) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.39 (3.69 - 5.15) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.39 (3.68 - 5.17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.33 (3.65 - 5.07) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.22 (3.52 - 4.96) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.08 (3.37 - 4.83) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.95 (3.23 - 4.76) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.87 (3.12 - 4.70) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.82 (3.09 - 4.67) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (3.05 - 4.63) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.72 (3.01 - 4.55) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.67 (2.95 - 4.51) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.62 (2.91 - 4.48) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.48 (2.81 - 4.24) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.8 2021 Survey/reported Georgia National Center for Disease Control and Public Health, 2022
5.4 2015 Survey/reported Hagan et al, 2019
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
1.25 (0.90 - 1.27) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
8.9 2018 Survey/reported Averhoff A et al, 2020
6.7 (5.60 - 7.30) 2014 Survey/reported Gower et al, 2014
7.7 (6.70 - 8.90) 2015 Survey/reported Hagan et al, 2015
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
69.1 (58 - 80.20) 2015 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
165,000 (120,000 - 169,000) 2015 Modelled Blach et al, 2017
189,937 (152,918 - 235,373) 1990 Modelled IHME, GBD 2019 (accessed 2022)
191,404 (153,354 - 235,034) 1991 Modelled IHME, GBD 2019 (accessed 2022)
192,198 (154,875 - 234,789) 1992 Modelled IHME, GBD 2019 (accessed 2022)
192,355 (155,821 - 235,489) 1993 Modelled IHME, GBD 2019 (accessed 2022)
191,959 (155,566 - 234,776) 1994 Modelled IHME, GBD 2019 (accessed 2022)
191,192 (154,099 - 232,822) 1995 Modelled IHME, GBD 2019 (accessed 2022)
192,059 (157,301 - 230,852) 1996 Modelled IHME, GBD 2019 (accessed 2022)
194,991 (161,159 - 231,890) 1997 Modelled IHME, GBD 2019 (accessed 2022)
198,120 (165,530 - 233,978) 1998 Modelled IHME, GBD 2019 (accessed 2022)
199,776 (167,211 - 234,203) 1999 Modelled IHME, GBD 2019 (accessed 2022)
198,510 (166,486 - 233,951) 2000 Modelled IHME, GBD 2019 (accessed 2022)
194,557 (163,155 - 228,663) 2001 Modelled IHME, GBD 2019 (accessed 2022)
189,406 (159,242 - 222,052) 2002 Modelled IHME, GBD 2019 (accessed 2022)
183,813 (155,074 - 215,001) 2003 Modelled IHME, GBD 2019 (accessed 2022)
178,612 (150,457 - 208,512) 2004 Modelled IHME, GBD 2019 (accessed 2022)
174,581 (146,577 - 204,071) 2005 Modelled IHME, GBD 2019 (accessed 2022)
171,685 (145,181 - 200,552) 2006 Modelled IHME, GBD 2019 (accessed 2022)
169,239 (143,400 - 197,180) 2007 Modelled IHME, GBD 2019 (accessed 2022)
166,991 (141,558 - 195,124) 2008 Modelled IHME, GBD 2019 (accessed 2022)
164,699 (139,675 - 192,344) 2009 Modelled IHME, GBD 2019 (accessed 2022)
162,260 (137,494 - 189,867) 2010 Modelled IHME, GBD 2019 (accessed 2022)
157,662 (133,490 - 184,361) 2011 Modelled IHME, GBD 2019 (accessed 2022)
150,364 (127,073 - 177,511) 2012 Modelled IHME, GBD 2019 (accessed 2022)
142,472 (118,754 - 170,174) 2013 Modelled IHME, GBD 2019 (accessed 2022)
135,950 (112,294 - 164,208) 2014 Modelled IHME, GBD 2019 (accessed 2022)
132,637 (108,689 - 161,967) 2015 Modelled IHME, GBD 2019 (accessed 2022)
131,955 (107,415 - 160,551) 2016 Modelled IHME, GBD 2019 (accessed 2022)
131,275 (106,105 - 159,746) 2017 Modelled IHME, GBD 2019 (accessed 2022)
129,848 (105,058 - 157,905) 2018 Modelled IHME, GBD 2019 (accessed 2022)
127,352 (102,992 - 155,505) 2019 Modelled IHME, GBD 2019 (accessed 2020)
127,883 (103,502 - 156,065) 2019 Modelled IHME, GBD 2019 (accessed 2022)
48,600 2021 Survey/reported Georgia National Center for Disease Control and Public Health, 2022
150,000 2015 Survey/reported Hagan et al, 2019
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
11,300 (8,200 - 11,500) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
10 (7.47 - 13.40) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5.91 (4.30 - 8.07) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6.07 (4.50 - 8.24) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.19 (4.65 - 8.42) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.23 (4.62 - 8.29) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.09 (4.53 - 8.07) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.01 (4.48 - 7.91) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5.99 (4.46 - 7.94) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7.73 (6 - 9.94) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.46 - 9.19) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.36 (4.84 - 8.41) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8.04 (6.36 - 10.19) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8.07 (6.32 - 10.19) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8.06 (6.37 - 10.21) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8.12 (6.32 - 10.31) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8.01 (6.23 - 10.16) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7.84 (6.06 - 10.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7.89 (6.11 - 10.02) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7.82 (5.97 - 10.06) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8.2 (6.25 - 10.52) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8.86 (6.78 - 11.48) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8.5 (6.49 - 10.97) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9.11 (6.97 - 11.81) 2011 Modelled IHME, GBD 2019 (accessed 2022)
9.27 (7.09 - 11.99) 2012 Modelled IHME, GBD 2019 (accessed 2022)
9.52 (7.32 - 12.28) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9.47 (7.33 - 12.30) 2014 Modelled IHME, GBD 2019 (accessed 2022)
9.71 (7.58 - 12.73) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10.21 (7.79 - 13.52) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10.08 (7.84 - 13.12) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10.02 (7.47 - 13.36) 2019 Modelled IHME, GBD 2019 (accessed 2022)
10.18 (7.72 - 13.55) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
425 2016 Modelled WHO
367 (274 - 490) 2019 Modelled IHME, GBD 2019 (accessed 2022)
367 (274 - 490) 2019 Modelled IHME, GBD 2019 (accessed 2020)
376 (286 - 501) 2018 Modelled IHME, GBD 2019 (accessed 2022)
381 (291 - 504) 2017 Modelled IHME, GBD 2019 (accessed 2022)
379 (295 - 494) 2016 Modelled IHME, GBD 2019 (accessed 2022)
368 (288 - 483) 2015 Modelled IHME, GBD 2019 (accessed 2022)
362 (281 - 471) 2014 Modelled IHME, GBD 2019 (accessed 2022)
367 (282 - 474) 2013 Modelled IHME, GBD 2019 (accessed 2022)
361 (276 - 467) 2012 Modelled IHME, GBD 2019 (accessed 2022)
359 (274 - 465) 2011 Modelled IHME, GBD 2019 (accessed 2022)
353 (270 - 457) 2010 Modelled IHME, GBD 2019 (accessed 2022)
343 (262 - 442) 2009 Modelled IHME, GBD 2019 (accessed 2022)
335 (256 - 430) 2008 Modelled IHME, GBD 2019 (accessed 2022)
324 (248 - 417) 2007 Modelled IHME, GBD 2019 (accessed 2022)
330 (255 - 424) 2006 Modelled IHME, GBD 2019 (accessed 2022)
338 (261 - 429) 2005 Modelled IHME, GBD 2019 (accessed 2022)
354 (276 - 450) 2004 Modelled IHME, GBD 2019 (accessed 2022)
356 (277 - 452) 2003 Modelled IHME, GBD 2019 (accessed 2022)
366 (287 - 463) 2002 Modelled IHME, GBD 2019 (accessed 2022)
374 (295 - 473) 2001 Modelled IHME, GBD 2019 (accessed 2022)
380 (301 - 482) 2000 Modelled IHME, GBD 2019 (accessed 2022)
373 (290 - 479) 1999 Modelled IHME, GBD 2019 (accessed 2022)
351 (269 - 452) 1998 Modelled IHME, GBD 2019 (accessed 2022)
319 (243 - 422) 1997 Modelled IHME, GBD 2019 (accessed 2022)
306 (227 - 405) 1996 Modelled IHME, GBD 2019 (accessed 2022)
312 (232 - 410) 1995 Modelled IHME, GBD 2019 (accessed 2022)
329 (243 - 437) 1994 Modelled IHME, GBD 2019 (accessed 2022)
326 (243 - 431) 1993 Modelled IHME, GBD 2019 (accessed 2022)
335 (252 - 456) 1992 Modelled IHME, GBD 2019 (accessed 2022)
332 (246 - 451) 1991 Modelled IHME, GBD 2019 (accessed 2022)
325 (237 - 445) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
5 (3 - 6) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 7) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 1995 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1996 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 1998 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 1999 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 25) 2000 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 2001 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2004 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2002 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 16) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 13) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 13) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2008 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2009 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2010 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2013 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2011 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2012 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 18) 2014 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 18) 2015 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2016 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2017 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 19) 2018 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2019 Modelled IHME, GBD 2019 (accessed 2022)
34 (25 - 43) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons initiating HCV treatment

National
Download
Value Year Type Source
52,594 2018 Survey/reported Georgia National Center for Disease Control and Public Health, 2022
64,537 2019 Survey/reported Georgia National Center for Disease Control and Public Health, 2022
69,192 2020 Survey/reported Georgia National Center for Disease Control and Public Health, 2022
Showing out of
Show more

Number of persons treated for HCV

National
Download
Value Year Type Source
5,941 2015 Survey/reported WHO, 2018
21,654 2016 Survey/reported WHO, 2018
19,514 2016 Survey/reported Hep Test Webinar Presentation- Maia Alkhazashvili
14,789 2017 Survey/reported Hep Test Webinar Presentation- Maia Alkhazashvili
10,202 2018 Survey/reported Hep Test Webinar Presentation- Maia Alkhazashvili
11,956 2019 Survey/reported Hep Test Webinar Presentation- Maia Alkhazashvili
7,251 2020 Survey/reported Hep Test Webinar Presentation- Maia Alkhazashvili
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
31 (16 - 271) 2015 Survey/reported Georgia National Centre for Disease Control and Public Health, 2015; Curatio International Foundation, 2015; Eurasia Harm Reduction Network, 2015
78 2021 Survey/reported Georgia Technical Adviosry Group
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.9 (3.10 - 4.80) 2015 Survey/reported Curatio International Foundation, 2015

Proportion of persons living with HCV diagnosed

National
Download
Value (%) Year Type Source
0.6 2020 Survey/reported Georgia National Center for Disease Control and Public Health, 2022

Price of HCV cure (Average price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
0 2019 Survey/reported WHO, 2021

Price of HCV cure (Cheapest price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
0 2019 Survey/reported WHO, 2021
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2003
Eligible for HBV generic medicines
HBV elimination goal
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based, Birth cohort
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

Resources